Post by Merck Healthcare
720,862 followers
Our collaboration with Saturnus Bio, a Versant Ventures-founded biotech, is aimed at establishing a foundational portfolio in rare genetic cardiomyopathies focusing on targeted gene modulation. Through this research-stage partnership, we can build upon our advanced technology and data science to accelerate the discovery and delivery of breakthrough medicines and ultimately, bring more medicines, to more patients, faster #AsOneForPatients. Read more here: https://lnkd.in/eBSs7p8H
Video Content